Hengdian Pharmaceuticals (301211.SZ) has received a drug registration certificate.

Zhijun Finance and Economics APP news, Hengdi Pharmaceutical (301211.SZ) announced that the company recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for Torasemide Injection. Torasemide is a highly efficient and long-acting loop diuretic, suitable for the long-term management of heart failure, liver cirrhosis, and renal edema. Its oral bioavailability is high and the risk of hypokalemia is relatively low. Torasemide Injection is classified as a Class 3 chemical drug for registration. It was evaluated and approved based on technical requirements consistent with the quality and efficacy of reference products, and its approval is considered equivalent to passing the evaluation of generic drug quality and efficacy consistency.